Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460371
Filing Date
2012-11-08
Accepted
2012-11-08 16:04:49
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d403426d10q.htm 10-Q 607832
2 2ND AMENDMENT TO API COMMERICAL SUPPLY AGREEMENT d403426dex101.htm EX-10.1 21188
3 SECTION 302 CEO CERTIFICATION d403426dex311.htm EX-31.1 10248
4 SECTION 302 PFO CERTIFICATION d403426dex312.htm EX-31.2 10040
5 SECTION 906 CEO AND PFO CERTIFICATION d403426dex321.htm EX-32.1 5853
  Complete submission text file 0001193125-12-460371.txt   4070300

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amrn-20120930.xml EX-101.INS 489669
7 XBRL TAXONOMY EXTENSION SCHEMA amrn-20120930.xsd EX-101.SCH 38836
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20120930_cal.xml EX-101.CAL 32338
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20120930_def.xml EX-101.DEF 216109
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20120930_lab.xml EX-101.LAB 323341
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20120930_pre.xml EX-101.PRE 246402
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-176897 | Film No.: 121190084
SIC: 2834 Pharmaceutical Preparations